Markus Bänziger - Concepedia

Author

Markus Bänziger

Also Known As

Banziger, M., Bänziger, Markus, Markus Bänziger

Publications

294

Citations

H-Index

Concepts

All Affiliations

Markus Bänziger is an author at Novartis (Switzerland) specializing in natural sciences, drug discovery, and medicinal chemistry.

#	Concept	H-Index	Publications	Citations
1	Natural Sciences	2	2	127
2	Biochemistry	2	2	127
3	Engineering	1	1	99
4	Medicine	1	1	28
5	Chemical Engineering	1	1	99

Markus Bänziger

Publications

250

Citations

H-Index

Page 1

	Year	Citations
Development and Scale-Up of the Electrochemical Dehalogenation for the Synthesis of a Key Intermediate for NS5A Inhibitors Christoph Gütz, Markus Bänziger, C. Bucher, Organic Process Research & Development Combinatorial ChemistryKey IntermediateEngineeringEnergy ConversionChemistry	2015	99
A Novel Cathode Material for Cathodic Dehalogenation of 1,1‐Dibromo Cyclopropane Derivatives Christoph Gütz, Maximilian Selt, Markus Bänziger, Chemistry - A European Journal	2015	86
The development of a practical synthesis of the potent and selective somatostatin sst3 receptor antagonist [4-(3,4-difluoro-phenyl)-piperazine-1-yl]-{(4S,4aS,8aR)-2[(S)-3-(6-methoxy-pyridin-3-yl)-2-methyl-propyl]-decahydroisoquinoline-4-yl}-methanone (NVP-ACQ090) Markus Bänziger, Jacques Cercus, Hans Hirt, Tetrahedron Asymmetry Medicinal ChemistryPractical SynthesisBiochemistryMedicineNatural Sciences	2003	28
The Synthesis of a Novel Inhibitor of B-Raf Kinase Donatienne Denni-Dischert, Wolfgang Marterer, Markus Bänziger, Organic Process Research & Development	2005	27
A facile synthesis of (2R,3E)-4-iodobut-3-en-2-ol and (2S,3E)-4-iodobut-3-en-2-yl chloroacetate Markus Bänziger, Gareth Griffiths, John F. McGarrity Tetrahedron Asymmetry Facile SynthesisOrganic ChemistryChemistryHalogenationSynthetic Chemistry	1993	10

Page 1